Vivoryon Therapeutics to report H1 2026 results on August 6

The company also said it plans to hold its Annual General Meeting at the end of September 2026, outlining two upcoming corporate milestones.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.